RVT-1201
( DrugBank: - / KEGG DRUG: - )
1 disease
| 告示番号 | 疾患名（ページ内リンク） | 臨床試験数 |
|---|---|---|
| 86 | 肺動脈性肺高血圧症 | 10 |
86. 肺動脈性肺高血圧症
臨床試験数 : 1,205 / 薬物数 : 684 - (DrugBank : 124) / 標的遺伝子数 : 100 - 標的パスウェイ数 : 193
Showing 1 to 10 of 10 trials
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | EUCTR2020-004971-42-AT (EUCTR) | 21/12/202120211221 | 07/09/202120210907 | A Study of Rodatristat Ethyl in Patients With Pulmonary Arterial Hypertension (ELEVATE 2) | A Phase 2b, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Rodatristat Ethyl in Patients with Pulmonary Arterial Hypertension - ELEVATE 2 A Phase 2b, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Rodatri ... | Pulmonary Arterial Hypertension (PAH) MedDRA version: 21.1;Level: PT;Classification code 10037400;Term: Pulmonary hypertension;System Organ Class: 10038738 - Respiratory, thoracic and mediastinal disorders;Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08] Pulmonary Arterial Hypertension (PAH) MedDRA version: 21.1;Level: PT;Classification code 10037400;Te ... | Product Name: Rodatristat ethyl Product Code: RVT-1201 INN or Proposed INN: Rodatristat ethyl Other descriptive name: Rodatristat ethyl Product Name: Rodatristat ethyl Product Code: RVT-1201 INN or Proposed INN: Rodatristat ethyl Other des ... | Altavant Sciences GmbH | NULL | Authorised-recruitment may be ongoing or finished | Female: yes Male: yes | 90 | Phase 2 | Serbia;United States;Czechia;Spain;Ukraine;Austria;United Kingdom;Italy;France;Czech Republic;Canada;Poland;Belgium;Bulgaria;Germany;Latvia;Moldova, Republic of;Bosnia and Herzegovina Serbia;United States;Czechia;Spain;Ukraine;Austria;United Kingdom;Italy;France;Czech Republic;Canada ... | ||
| 2 | EUCTR2020-004971-42-DE (EUCTR) | 26/10/202120211026 | 19/04/202120210419 | A Study of Rodatristat Ethyl in Patients With Pulmonary Arterial Hypertension (ELEVATE 2) | A Phase 2b, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Rodatristat Ethyl in Patients with Pulmonary Arterial Hypertension - ELEVATE 2 A Phase 2b, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Rodatri ... | Pulmonary Arterial Hypertension (PAH) MedDRA version: 21.1;Level: PT;Classification code 10037400;Term: Pulmonary hypertension;System Organ Class: 10038738 - Respiratory, thoracic and mediastinal disorders;Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08] Pulmonary Arterial Hypertension (PAH) MedDRA version: 21.1;Level: PT;Classification code 10037400;Te ... | Product Name: Rodatristat ethyl Product Code: RVT-1201 INN or Proposed INN: Rodatristat ethyl Other descriptive name: Rodatristat ethyl Product Name: Rodatristat ethyl Product Code: RVT-1201 INN or Proposed INN: Rodatristat ethyl Other des ... | Altavant Sciences GmbH | NULL | Authorised-recruitment may be ongoing or finished | Female: yes Male: yes | 90 | Phase 2 | United States;Czechia;Ukraine;United Kingdom;Spain;Canada;Austria;Latvia;Czech Republic;Belgium;Moldova, Republic of;Poland;Italy;France;Bulgaria;Serbia;Bosnia and Herzegovina;Germany United States;Czechia;Ukraine;United Kingdom;Spain;Canada;Austria;Latvia;Czech Republic;Belgium;Mold ... | ||
| 3 | EUCTR2020-004971-42-BG (EUCTR) | 12/10/202120211012 | 05/07/202120210705 | A Study of Rodatristat Ethyl in Patients With Pulmonary Arterial Hypertension (ELEVATE 2) | A Phase 2b, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Rodatristat Ethyl in Patients with Pulmonary Arterial Hypertension - ELEVATE 2 A Phase 2b, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Rodatri ... | Pulmonary Arterial Hypertension (PAH) MedDRA version: 21.1;Level: PT;Classification code 10037400;Term: Pulmonary hypertension;System Organ Class: 10038738 - Respiratory, thoracic and mediastinal disorders;Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08] Pulmonary Arterial Hypertension (PAH) MedDRA version: 21.1;Level: PT;Classification code 10037400;Te ... | Product Name: Rodatristat ethyl Product Code: RVT-1201 INN or Proposed INN: Rodatristat ethyl Other descriptive name: Rodatristat ethyl Product Name: Rodatristat ethyl Product Code: RVT-1201 INN or Proposed INN: Rodatristat ethyl Other des ... | Altavant Sciences GmbH | NULL | Authorised-recruitment may be ongoing or finished | Female: yes Male: yes | 90 | Phase 2 | Serbia;United States;Czechia;Spain;Ukraine;Austria;United Kingdom;Italy;France;Czech Republic;Canada;Poland;Belgium;Bulgaria;Latvia;Germany;Moldova, Republic of;Bosnia and Herzegovina Serbia;United States;Czechia;Spain;Ukraine;Austria;United Kingdom;Italy;France;Czech Republic;Canada ... | ||
| 4 | EUCTR2020-004971-42-PL (EUCTR) | 20/08/202120210820 | 25/05/202120210525 | A Study of Rodatristat Ethyl in Patients With Pulmonary Arterial Hypertension (ELEVATE 2) | A Phase 2b, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Rodatristat Ethyl in Patients with Pulmonary Arterial Hypertension - ELEVATE 2 A Phase 2b, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Rodatri ... | Pulmonary Arterial Hypertension (PAH) MedDRA version: 21.1;Level: PT;Classification code 10037400;Term: Pulmonary hypertension;System Organ Class: 10038738 - Respiratory, thoracic and mediastinal disorders;Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08] Pulmonary Arterial Hypertension (PAH) MedDRA version: 21.1;Level: PT;Classification code 10037400;Te ... | Product Name: Rodatristat ethyl Product Code: RVT-1201 INN or Proposed INN: Rodatristat ethyl Other descriptive name: Rodatristat ethyl Product Name: Rodatristat ethyl Product Code: RVT-1201 INN or Proposed INN: Rodatristat ethyl Other des ... | Altavant Sciences GmbH | NULL | Authorised-recruitment may be ongoing or finished | Female: yes Male: yes | 90 | Phase 2 | Serbia;United States;Czechia;Spain;Ukraine;Austria;United Kingdom;Italy;France;Czech Republic;Canada;Poland;Belgium;Bulgaria;Latvia;Germany;Moldova, Republic of;Bosnia and Herzegovina Serbia;United States;Czechia;Spain;Ukraine;Austria;United Kingdom;Italy;France;Czech Republic;Canada ... | ||
| 5 | EUCTR2020-004971-42-CZ (EUCTR) | 22/07/202120210722 | 06/05/202120210506 | A Study of Rodatristat Ethyl in Patients With Pulmonary Arterial Hypertension (ELEVATE 2) | A Phase 2b, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Rodatristat Ethyl in Patients with Pulmonary Arterial Hypertension - ELEVATE 2 A Phase 2b, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Rodatri ... | Pulmonary Arterial Hypertension (PAH) MedDRA version: 21.1;Level: PT;Classification code 10037400;Term: Pulmonary hypertension;System Organ Class: 10038738 - Respiratory, thoracic and mediastinal disorders;Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08] Pulmonary Arterial Hypertension (PAH) MedDRA version: 21.1;Level: PT;Classification code 10037400;Te ... | Product Name: Rodatristat ethyl Product Code: RVT-1201 INN or Proposed INN: Rodatristat ethyl Other descriptive name: Rodatristat ethyl Product Name: Rodatristat ethyl Product Code: RVT-1201 INN or Proposed INN: Rodatristat ethyl Other des ... | Altavant Sciences GmbH | NULL | Authorised-recruitment may be ongoing or finished | Female: yes Male: yes | 90 | Phase 2 | Serbia;United States;Czechia;Spain;Ukraine;Austria;United Kingdom;Italy;France;Czech Republic;Canada;Poland;Belgium;Bulgaria;Latvia;Germany;Moldova, Republic of;Bosnia and Herzegovina Serbia;United States;Czechia;Spain;Ukraine;Austria;United Kingdom;Italy;France;Czech Republic;Canada ... | ||
| 6 | EUCTR2020-004971-42-ES (EUCTR) | 22/07/202120210722 | 22/07/202120210722 | A Study of Rodatristat Ethyl in Patients With Pulmonary Arterial Hypertension (ELEVATE 2) | A Phase 2b, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Rodatristat Ethyl in Patients with Pulmonary Arterial Hypertension - ELEVATE 2 A Phase 2b, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Rodatri ... | Pulmonary Arterial Hypertension (PAH) MedDRA version: 21.1;Level: PT;Classification code 10037400;Term: Pulmonary hypertension;System Organ Class: 10038738 - Respiratory, thoracic and mediastinal disorders;Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08] Pulmonary Arterial Hypertension (PAH) MedDRA version: 21.1;Level: PT;Classification code 10037400;Te ... | Product Name: Rodatristat ethyl Product Code: RVT-1201 INN or Proposed INN: Rodatristat ethyl Other descriptive name: Rodatristat ethyl Product Name: Rodatristat ethyl Product Code: RVT-1201 INN or Proposed INN: Rodatristat ethyl Other des ... | Altavant Sciences GmbH | NULL | Authorised-recruitment may be ongoing or finished | Female: yes Male: yes | 90 | Phase 2 | Serbia;United States;Czechia;Spain;Ukraine;Russian Federation;United Kingdom;Italy;France;Canada;Poland;Belgium;Bulgaria;Germany;Latvia;Bosnia and Herzegovina Serbia;United States;Czechia;Spain;Ukraine;Russian Federation;United Kingdom;Italy;France;Canada;Pol ... | ||
| 7 | EUCTR2020-004971-42-BE (EUCTR) | 12/07/202120210712 | 28/04/202120210428 | A Study of Rodatristat Ethyl in Patients With Pulmonary Arterial Hypertension (ELEVATE 2) | A Phase 2b, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Rodatristat Ethyl in Patients with Pulmonary Arterial Hypertension - ELEVATE 2 A Phase 2b, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Rodatri ... | Pulmonary Arterial Hypertension (PAH) MedDRA version: 21.1;Level: PT;Classification code 10037400;Term: Pulmonary hypertension;System Organ Class: 10038738 - Respiratory, thoracic and mediastinal disorders;Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08] Pulmonary Arterial Hypertension (PAH) MedDRA version: 21.1;Level: PT;Classification code 10037400;Te ... | Product Name: Rodatristat ethyl Product Code: RVT-1201 INN or Proposed INN: Rodatristat ethyl Other descriptive name: Rodatristat ethyl Product Name: Rodatristat ethyl Product Code: RVT-1201 INN or Proposed INN: Rodatristat ethyl Other des ... | Altavant Sciences GmbH | NULL | Authorised-recruitment may be ongoing or finished | Female: yes Male: yes | 90 | Phase 2 | Serbia;United States;Czechia;Spain;Ukraine;Russian Federation;United Kingdom;Italy;France;Canada;Belgium;Poland;Bulgaria;Germany;Latvia;Bosnia and Herzegovina Serbia;United States;Czechia;Spain;Ukraine;Russian Federation;United Kingdom;Italy;France;Canada;Bel ... | ||
| 8 | EUCTR2020-004971-42-LV (EUCTR) | 09/07/202120210709 | 22/04/202120210422 | A Study of Rodatristat Ethyl in Patients With Pulmonary Arterial Hypertension (ELEVATE 2) | A Phase 2b, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Rodatristat Ethyl in Patients with Pulmonary Arterial Hypertension - ELEVATE 2 A Phase 2b, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Rodatri ... | Pulmonary Arterial Hypertension (PAH) MedDRA version: 21.1;Level: PT;Classification code 10037400;Term: Pulmonary hypertension;System Organ Class: 10038738 - Respiratory, thoracic and mediastinal disorders;Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08] Pulmonary Arterial Hypertension (PAH) MedDRA version: 21.1;Level: PT;Classification code 10037400;Te ... | Product Name: Rodatristat ethyl Product Code: RVT-1201 INN or Proposed INN: Rodatristat ethyl Other descriptive name: Rodatristat ethyl Product Name: Rodatristat ethyl Product Code: RVT-1201 INN or Proposed INN: Rodatristat ethyl Other des ... | Altavant Sciences GmbH | NULL | Authorised-recruitment may be ongoing or finished | Female: yes Male: yes | 90 | Phase 2 | United States;Serbia;Czechia;Spain;Ukraine;Russian Federation;United Kingdom;Italy;France;Canada;Belgium;Poland;Bulgaria;Latvia;Germany;Bosnia and Herzegovina United States;Serbia;Czechia;Spain;Ukraine;Russian Federation;United Kingdom;Italy;France;Canada;Bel ... | ||
| 9 | EUCTR2020-004971-42-IT (EUCTR) | 05/07/202120210705 | 07/06/202120210607 | A Study of Rodatristat Ethyl in Patients With Pulmonary Arterial Hypertension (ELEVATE 2) | A Phase 2b, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Rodatristat Ethyl in Patients with Pulmonary Arterial Hypertension - ELEVATE 2 A Phase 2b, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Rodatri ... | Pulmonary Arterial Hypertension (PAH) MedDRA version: 21.1;Level: PT;Classification code 10037400;Term: Pulmonary hypertension;System Organ Class: 10038738 - Respiratory, thoracic and mediastinal disorders;Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08] Pulmonary Arterial Hypertension (PAH) MedDRA version: 21.1;Level: PT;Classification code 10037400;Te ... | Product Name: Rodatristat ethyl Product Code: [RVT-1201] INN or Proposed INN: Rodatristat ethyl Other descriptive name: Rodatristat ethyl Product Name: Rodatristat ethyl Product Code: [RVT-1201] INN or Proposed INN: Rodatristat ethyl Other d ... | Altavant Sciences GmbH | NULL | Authorised-recruitment may be ongoing or finished | Female: yes Male: yes | 90 | Phase 2 | Serbia;United States;Czechia;Spain;Ukraine;Russian Federation;United Kingdom;Italy;France;Canada;Belgium;Poland;Bulgaria;Germany;Latvia;Bosnia and Herzegovina Serbia;United States;Czechia;Spain;Ukraine;Russian Federation;United Kingdom;Italy;France;Canada;Bel ... | ||
| 10 | NCT03924154 (ClinicalTrials.gov) | August 1, 201920190801 | 5/4/201920190405 | A Study of RVT-1201 in Patients With Pulmonary Arterial Hypertension (ELEVATE 1) | A Phase 2a, Double-Blind, Placebo-Controlled Multicenter Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Effects of RVT-1201 in Patients With Pulmonary Arterial Hypertension A Phase 2a, Double-Blind, Placebo-Controlled Multicenter Study to Assess the Safety, Tolerability, P ... | Pulmonary Arterial Hypertension | Drug: RVT-1201;Drug: Placebo | Altavant Sciences GmbH | Altavant Sciences, Inc.;PPD | Terminated | 18 Years | 75 Years | All | 3 | Phase 2 | United States;Canada |